Covid-19: Vaccination Programme
Debate between Lord Sharpe of Epsom and Lord Wigley
Lord Sharpe of Epsom (Con)
I thank my noble friend for her question. She is right: the OECD’s Development Assistance Committee secretariat has now provided guidance for reporting donations of excess Covid-19 vaccine doses in 2021 in ODA. The UK is considering this guidance together with our other commitments and obligations and is actively engaging with the Development Assistance Committee secretariat on valuing Covid-19 vaccines in ODA assistance in 2021. The DAC secretariat will review its methodology for donations in 2022, and all donations to date have been to ODA-eligible countries.
Lord Wigley (PC)
My Lords, what consideration have the Government given to the possibility of offering tax incentives or financial aid for companies from the United Kingdom which might set up manufacturing plants in overseas countries so that they can help directly in those areas?
Lord Sharpe of Epsom (Con)
My Lords, I am not familiar with the tax incentives that may have been offered, but we have provided technical support to develop business cases for, for example, Biovac to manufacture vaccines in South Africa, the Institut Pasteur in Dakar, Senegal, and to the Moroccan Government. The technical support helped to catalyse investment that will see Covid-19 vaccines produced on the African continent in 2022. We also welcome the work of the COVAX supply chain and manufacturing task force, which brings together partners to identify immediate and longer-term actions to increase the volume and security of global vaccine supply.